vs

Side-by-side financial comparison of 60 DEGREES PHARMACEUTICALS, INC. (SXTP) and ATIF Holdings Ltd (ZBAI). Click either name above to swap in a different company.

60 DEGREES PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($303.4K vs $250.0K, roughly 1.2× ATIF Holdings Ltd). 60 DEGREES PHARMACEUTICALS, INC. runs the higher net margin — -474.2% vs -635.6%, a 161.4% gap on every dollar of revenue. On growth, 60 DEGREES PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (25.6% vs 25.0%). Over the past eight quarters, 60 DEGREES PHARMACEUTICALS, INC.'s revenue compounded faster (69.4% CAGR vs -8.7%).

Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.

ATIF Holdings Ltd is a professional business advisory service provider that mainly serves small and medium-sized enterprises across the Asia-Pacific region. It offers corporate strategic consulting, fundraising guidance, cross-border expansion support, and industry resource matching services for clients in technology, consumer goods, manufacturing and other key sectors.

SXTP vs ZBAI — Head-to-Head

Bigger by revenue
SXTP
SXTP
1.2× larger
SXTP
$303.4K
$250.0K
ZBAI
Growing faster (revenue YoY)
SXTP
SXTP
+0.6% gap
SXTP
25.6%
25.0%
ZBAI
Higher net margin
SXTP
SXTP
161.4% more per $
SXTP
-474.2%
-635.6%
ZBAI
Faster 2-yr revenue CAGR
SXTP
SXTP
Annualised
SXTP
69.4%
-8.7%
ZBAI

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
SXTP
SXTP
ZBAI
ZBAI
Revenue
$303.4K
$250.0K
Net Profit
$-1.4M
$-1.6M
Gross Margin
60.2%
Operating Margin
-632.0%
-75.6%
Net Margin
-474.2%
-635.6%
Revenue YoY
25.6%
25.0%
Net Profit YoY
29.7%
-96.8%
EPS (diluted)
$-8.26
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SXTP
SXTP
ZBAI
ZBAI
Q4 25
$303.4K
Q3 25
$437.6K
Q2 25
$100.9K
$250.0K
Q1 25
$163.6K
$200.0K
Q4 24
$241.6K
Q3 24
$135.3K
$270.0K
Q2 24
$125.0K
$200.0K
Q1 24
$105.7K
$25.0K
Net Profit
SXTP
SXTP
ZBAI
ZBAI
Q4 25
$-1.4M
Q3 25
$-2.3M
Q2 25
$-1.7M
$-1.6M
Q1 25
$-1.9M
$-1.9M
Q4 24
$-2.0M
Q3 24
$-2.2M
Q2 24
$-4.2M
$-807.6K
Q1 24
$430.5K
$-407.6K
Gross Margin
SXTP
SXTP
ZBAI
ZBAI
Q4 25
60.2%
Q3 25
-22.9%
Q2 25
50.4%
Q1 25
55.2%
Q4 24
51.1%
Q3 24
17.4%
Q2 24
28.3%
Q1 24
38.1%
Operating Margin
SXTP
SXTP
ZBAI
ZBAI
Q4 25
-632.0%
Q3 25
-531.4%
Q2 25
-1590.0%
-75.6%
Q1 25
-1168.4%
-175.4%
Q4 24
-854.7%
Q3 24
-1566.0%
Q2 24
-3351.8%
-260.6%
Q1 24
-1270.4%
-2190.1%
Net Margin
SXTP
SXTP
ZBAI
ZBAI
Q4 25
-474.2%
Q3 25
-529.3%
Q2 25
-1717.7%
-635.6%
Q1 25
-1147.4%
-951.7%
Q4 24
-846.3%
Q3 24
-1596.4%
Q2 24
-3339.0%
-403.8%
Q1 24
407.4%
-1630.6%
EPS (diluted)
SXTP
SXTP
ZBAI
ZBAI
Q4 25
$-8.26
Q3 25
$-0.66
Q2 25
$-1.25
$-0.09
Q1 25
$-1.56
$-0.16
Q4 24
$-51.96
Q3 24
$-2.92
Q2 24
$-21.12
$-0.08
Q1 24
$1.83
$-0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SXTP
SXTP
ZBAI
ZBAI
Cash + ST InvestmentsLiquidity on hand
$2.8M
$7.8M
Total DebtLower is stronger
$150.0K
Stockholders' EquityBook value
$3.5M
$8.4M
Total Assets
$5.4M
$8.7M
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SXTP
SXTP
ZBAI
ZBAI
Q4 25
$2.8M
Q3 25
$4.1M
Q2 25
$2.0M
$7.8M
Q1 25
$3.5M
$8.0M
Q4 24
$3.4M
Q3 24
$5.0M
$1.7M
Q2 24
$1.6M
$2.3M
Q1 24
$139.2K
Total Debt
SXTP
SXTP
ZBAI
ZBAI
Q4 25
$150.0K
Q3 25
$150.0K
Q2 25
$150.0K
Q1 25
$150.0K
Q4 24
$150.0K
Q3 24
$150.0K
Q2 24
$150.0K
Q1 24
$150.0K
Stockholders' Equity
SXTP
SXTP
ZBAI
ZBAI
Q4 25
$3.5M
Q3 25
$4.4M
Q2 25
$2.4M
$8.4M
Q1 25
$4.1M
$7.9M
Q4 24
$4.0M
Q3 24
$6.0M
$1.8M
Q2 24
$3.0M
$3.1M
Q1 24
$7.2M
$506.3K
Total Assets
SXTP
SXTP
ZBAI
ZBAI
Q4 25
$5.4M
Q3 25
$6.7M
Q2 25
$4.2M
$8.7M
Q1 25
$6.0M
$8.6M
Q4 24
$5.8M
Q3 24
$7.4M
$3.0M
Q2 24
$4.3M
$3.3M
Q1 24
$8.4M
$2.5M
Debt / Equity
SXTP
SXTP
ZBAI
ZBAI
Q4 25
0.04×
Q3 25
0.03×
Q2 25
0.06×
Q1 25
0.04×
Q4 24
0.04×
Q3 24
0.02×
Q2 24
0.05×
Q1 24
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SXTP
SXTP
ZBAI
ZBAI
Operating Cash FlowLast quarter
$-1.7M
$-939.0K
Free Cash FlowOCF − Capex
$-1.8M
FCF MarginFCF / Revenue
-584.2%
Capex IntensityCapex / Revenue
26.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SXTP
SXTP
ZBAI
ZBAI
Q4 25
$-1.7M
Q3 25
$-2.1M
Q2 25
$-1.5M
$-939.0K
Q1 25
$-1.6M
$-395.1K
Q4 24
$-1.6M
Q3 24
$-1.7M
Q2 24
$-1.2M
$-62.6K
Q1 24
$-1.1M
$-212.8K
Free Cash Flow
SXTP
SXTP
ZBAI
ZBAI
Q4 25
$-1.8M
Q3 25
$-2.1M
Q2 25
$-1.5M
Q1 25
$-1.6M
Q4 24
Q3 24
$-1.7M
Q2 24
Q1 24
$-213.5K
FCF Margin
SXTP
SXTP
ZBAI
ZBAI
Q4 25
-584.2%
Q3 25
-484.2%
Q2 25
-1483.6%
Q1 25
-978.3%
Q4 24
Q3 24
-1252.8%
Q2 24
Q1 24
-854.1%
Capex Intensity
SXTP
SXTP
ZBAI
ZBAI
Q4 25
26.3%
Q3 25
2.3%
Q2 25
46.9%
Q1 25
1.6%
Q4 24
Q3 24
10.2%
Q2 24
0.0%
Q1 24
3.0%
Cash Conversion
SXTP
SXTP
ZBAI
ZBAI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
-2.65×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons